Literature DB >> 30459208

Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems.

Jessica Chubak1,2, Dale McLerran3, Yingye Zheng3, Amit G Singal4,5, Douglas A Corley6, V Paul Doria-Rose7, Chyke A Doubeni8, Aruna Kamineni9, Jennifer S Haas10, Ethan A Halm4,5, Celette Sugg Skinner4, Ann G Zauber11, Karen J Wernli9, Elisabeth F Beaber.   

Abstract

BACKGROUND: To reduce colorectal cancer incidence and mortality, experts recommend surveillance colonoscopy 3 years after advanced adenoma removal. Little is known about adherence to that interval.
METHODS: We describe patterns of and factors associated with subsequent colonoscopy among persons with ≥3 adenomas and/or ≥1 adenoma with villous/tubulovillous histology in four U.S. integrated healthcare delivery systems. We report Kaplan-Meier estimators of the cumulative percentage of patients undergoing colonoscopy 6 months to 3.5 years after an index colonoscopy with high-risk findings. Combining data from three healthcare systems, we used multivariable logistic regression with inverse probability of censoring weights to estimate ORs and 95% confidence intervals (CI) for associations between patient characteristics and receipt of subsequent colonoscopy.
RESULTS: Among 6,909 persons with advanced adenomas, the percent receiving a subsequent colonoscopy 6 months to 3.5 years later ranged from 18.3% (95% CI: 11.7%-27.8%) to 59.5% (95% CI: 53.8%-65.2%) across healthcare systems. Differences remained significant in the multivariable model. Patients with ≥3 adenomas were more likely than those with 1 to 2 villous/tubulovillous adenomas to undergo subsequent colonoscopy. Subsequent colonoscopy was also more common for patients ages 60-74 and less common for patients ages 80 to 89 compared with those ages 50 to 54 years at their index colonoscopy. Sex, race/ethnicity, and comorbidity index score were generally not associated with subsequent colonoscopy receipt.
CONCLUSIONS: Colonoscopy within the recommended interval following advanced adenoma was underutilized and varied by healthcare system, age, and number of adenomas. IMPACT: Strategies to improve adherence to surveillance colonoscopy following advanced adenomas are needed. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 30459208      PMCID: PMC6324953          DOI: 10.1158/1055-9965.EPI-18-0452

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  13 in total

Review 1.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  David A Lieberman; Douglas K Rex; Sidney J Winawer; Francis M Giardiello; David A Johnson; Theodore R Levin
Journal:  Gastroenterology       Date:  2012-07-03       Impact factor: 22.682

2.  Use of colonoscopy for polyp surveillance in Medicare beneficiaries.

Authors:  Gregory S Cooper; Tzuyung D Kou; Jill S Barnholtz Sloan; Siran M Koroukian; Mark D Schluchter
Journal:  Cancer       Date:  2013-02-21       Impact factor: 6.860

3.  Surveillance patterns and polyp recurrence following diagnosis and excision of colorectal polyps in a medicare population.

Authors:  Mayur M Amonkar; Timothy L Hunt; Zhiyuan Zhou; Xiaodong Jin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

Review 4.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Jennifer S Lin; Margaret A Piper; Leslie A Perdue; Carolyn M Rutter; Elizabeth M Webber; Elizabeth O'Connor; Ning Smith; Evelyn P Whitlock
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

5.  Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.

Authors:  Elisabeth F Beaber; Jane J Kim; Marilyn M Schapira; Anna N A Tosteson; Ann G Zauber; Ann M Geiger; Aruna Kamineni; Donald L Weaver; Jasmin A Tiro
Journal:  J Natl Cancer Inst       Date:  2015-05-07       Impact factor: 13.506

6.  Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial.

Authors:  Adeyinka O Laiyemo; Paul F Pinsky; Pamela M Marcus; Elaine Lanza; Amanda J Cross; Arthur Schatzkin; Robert E Schoen
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12-13       Impact factor: 11.382

7.  The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium.

Authors:  Jasmin A Tiro; Aruna Kamineni; Theodore R Levin; Yingye Zheng; Joanne S Schottinger; Carolyn M Rutter; Douglas A Corley; Celette S Skinner; Jessica Chubak; Chyke A Doubeni; Ethan A Halm; Samir Gupta; Karen J Wernli; Carrie Klabunde
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-10       Impact factor: 4.254

8.  Adenoma detection rate and risk of colorectal cancer and death.

Authors:  Douglas A Corley; Christopher D Jensen; Amy R Marks; Wei K Zhao; Jeffrey K Lee; Chyke A Doubeni; Ann G Zauber; Jolanda de Boer; Bruce H Fireman; Joanne E Schottinger; Virginia P Quinn; Nirupa R Ghai; Theodore R Levin; Charles P Quesenberry
Journal:  N Engl J Med       Date:  2014-04-03       Impact factor: 91.245

9.  Underuse of surveillance colonoscopy in patients at increased risk of colorectal cancer.

Authors:  Caitlin C Murphy; Carmen L Lewis; Carol E Golin; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2014-11-11       Impact factor: 10.864

10.  Utilization of surveillance after polypectomy in the medicare population--a cohort study.

Authors:  Iris Lansdorp-Vogelaar; Stacey Fedewa; Chun Chieh Lin; Katherine S Virgo; Ahmedin Jemal
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

View more
  6 in total

1.  The impact of cumulative colorectal cancer screening delays: A simulation study.

Authors:  Carolyn M Rutter; John M Inadomi; Christopher E Maerzluft
Journal:  J Med Screen       Date:  2021-12-13       Impact factor: 1.687

2.  Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population.

Authors:  Jeffrey K Lee; Christopher D Jensen; Theodore R Levin; Chyke A Doubeni; Ann G Zauber; Jessica Chubak; Aruna S Kamineni; Joanne E Schottinger; Nirupa R Ghai; Natalia Udaltsova; Wei K Zhao; Bruce H Fireman; Charles P Quesenberry; E John Orav; Celette S Skinner; Ethan A Halm; Douglas A Corley
Journal:  Gastroenterology       Date:  2019-10-04       Impact factor: 22.682

3.  Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.

Authors:  Theodore R Levin; Christopher D Jensen; Neetu M Chawla; Lori C Sakoda; Jeffrey K Lee; Wei K Zhao; Molly A Landau; Ariel Herm; Eryn Eby; Charles P Quesenberry; Douglas A Corley
Journal:  Gastroenterology       Date:  2020-07-20       Impact factor: 22.682

4.  Clinical care pathway program versus open-access system: a study on appropriateness, quality, and efficiency in the delivery of colonoscopy in the colorectal cancer.

Authors:  Giovanna Del Vecchio Blanco; Rami Dwairi; Mario Giannelli; Giampiero Palmieri; Vincenzo Formica; Ilaria Portarena; Enrico Grasso; Laura Di Iorio; Michela Benassi; Emilia Anna Giudice; Antonella Nardecchia; Piero Rossi; Mario Roselli; Giuseppe Sica; Giovanni Monteleone; Omero Alessandro Paoluzi
Journal:  Intern Emerg Med       Date:  2021-02-08       Impact factor: 3.397

5.  Impact of Community Referral on Colonoscopy Quality Metrics in a Veterans Affairs Medical Center.

Authors:  Vincent Petros; Erin Tsambikos; Mohammad Madhoun; William M Tierney
Journal:  Clin Transl Gastroenterol       Date:  2022-01-01       Impact factor: 4.396

Review 6.  Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review.

Authors:  Carolyn M Rutter; Amy B Knudsen; Jennifer S Lin; Kathryn E Bouskill
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-11-03       Impact factor: 4.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.